RVP logo

Retractable Technologies, Inc. Stock Price

NYSEAM:RVP Community·US$27.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

RVP Share Price Performance

US$1.03
0.28 (36.42%)
US$1.03
0.28 (36.42%)
Price US$1.03

RVP Community Narratives

There are no narratives available yet.

Recent RVP News & Updates

Retractable Technologies, Inc. Key Details

US$38.2m

Revenue

US$40.8m

Cost of Revenue

-US$2.6m

Gross Profit

US$6.4m

Other Expenses

-US$9.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.30
Gross Margin
-6.86%
Net Profit Margin
-23.51%
Debt/Equity Ratio
1.4%

Retractable Technologies, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Adequate balance sheet with very low risk.

2 Risks
0 Rewards

About RVP

Founded
1994
Employees
224
CEO
Thomas Shaw
WebsiteView website
www.retractable.com

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: 0.3%
  • 3 Months: 8.5%
  • 1 Year: 17.3%
  • Year to Date: 15.0%
In the last week, the market has been flat. Meanwhile, the market is actually up 17% over the past year. Earnings are forecast to grow by 15% annually. Market details ›